Associate Director – Executive Director, Clinical Science & Medical Affairs

The Senior Clinical Scientist and Medical Affairs Lead will help shape the scientific direction of Aveta Biomics’ clinical portfolio and translate emerging data into clear, credible medical insights. The primary focus will be the global Phase 3 AVTA
30‑01 program in head and neck cancer, with additional responsibility for glioblastoma, oral dysplasia, and emerging development programs.

Working closely with the CMO and cross-functional teams, this individual will combine clinical science, rigorous data interpretation, and external scientific engagement to strengthen study delivery, evidence generation, and development strategy. The position may be filled at the Associate Director, Director, Senior Director or Executive Director level, depending on the candidate’s experience and qualifications.

• Provide clinical-science leadership across Aveta’s development programs, contributing to study design, protocols, Investigator’s Brochures, eCRFs, data-review and statistical analysis plans, Clinical Study Reports, and regulatory submissions.
• Lead scientific review and interpretation of clinical data, integrating efficacy, safety, exposure, laboratory, imaging, pathology, ctDNA, biomarker, translational, and patient-reported outcomes. Identify meaningful trends, inconsistencies, outliers, and potential protocol deviations and elevate medically important findings appropriately.
• Translate complex clinical and translational findings into actionable insights for development strategy, internal decision-making, regulatory discussions, and scientific communication, working across Clinical Operations, Data Management, Biostatistics, Translational Medicine, Pharmacovigilance, and the CRO.
• Lead medical-affairs and external scientific engagement, building trusted relationships with investigators, KOLs, academic institutions, cooperative groups, and scientific organizations and supporting advisory boards, investigator meetings, scientific workshops, congresses, and training.
• Coordinate external scientific collaborations and investigator-sponsored research, evaluating opportunities for scientific value and strategic fit and establishing clear objectives, governance, milestones, data/sample requirements, publication terms, and deliverables while protecting confidential and restricted information.
• Drive evidence generation and scientific communication, including publication planning, abstracts, posters, presentations, manuscripts, congress submissions, and scientific materials, ensuring accurate, balanced, and evidence-based interpretation.
• Bring external scientific insights into Aveta, monitoring emerging science, treatment guidelines, competitive developments, unmet needs, and evolving clinical practice and translating these insights into clinical and portfolio strategy.
• Partner across functions on development and portfolio strategy, providing scientific input into study design, endpoints, biomarkers, regulatory interactions, evidence-generation priorities, portfolio assessments, partnering discussions, and consistent implementation of scientific requirements across study execution.

• PhD, PharmD, MD, MD/PhD, or comparable advanced scientific or healthcare degree, with 5+ years of relevant biotechnology or pharmaceutical experience in clinical development, clinical science, medical affairs, or translational medicine.
• Strong oncology experience preferred; experience in head and neck cancer, immuno-oncology, neuro-oncology, or cancer interception is particularly valuable.
• Hands‑on experience reviewing and interpreting clinical and translational data, including EDC records, listings, tables, figures, and statistical outputs.
• Experience developing clinical, regulatory, and scientific documents, including protocols, Investigator’s Brochures, Clinical Study Reports, regulatory materials, abstracts, presentations, and manuscripts.
• Strong understanding of clinical‑trial design, drug development, ICH/GCP, publication standards, and medical‑affairs compliance.
• Strong scientific writing, presentation, and relationship‑building skills, with the ability to communicate complex science clearly and work effectively with investigators, KOLs, academic collaborators, and cross‑functional teams.
• Ability to travel domestically and internationally for investigator meetings, advisory boards, congresses, and collaborator meetings.